Maravai Lifesciences Holdings Statistics
Want to see MRVI full AI Analyst Report?
Maravai Lifesciences Holdings (MRVI) Stock Statistics & Valuation Metrics
Total Valuation
Maravai Lifesciences Holdings has a market cap or net worth of $1.92B. The enterprise value is $1.39B.
- Market Cap
- $1.92B
- Enterprise Value
- $1.39B
Share Statistics
Maravai Lifesciences Holdings has 149,254,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 149,254,470
- Owned by Insiders
- 3.24%
- Owned by Institutions
- 71.36%
Financial Efficiency
Maravai Lifesciences Holdings’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -0.91%.
- Return on Equity (ROE)
- -0.62
- Return on Assets (ROA)
- -0.17
- Return on Invested Capital (ROIC)
- -0.91%
- Return on Capital Employed (ROCE)
- -0.01
- Revenue Per Employee
- 453.03K
- Profits Per Employee
- -318.96K
- Employee Count
- 410
- Asset Turnover
- 0.24
- Inventory Turnover
- 3.76
Valuation Ratios
The current PE Ratio of Maravai Lifesciences Holdings is -16.57. Maravai Lifesciences Holdings’s PEG ratio is -0.27.
- PE Ratio
- -16.57
- PS Ratio
- 9.84
- PB Ratio
- 5.62
- Price to FCF
- -167.22
- Price to Operating Cash Flow
- -215.88
- PEG Ratio
- -0.27
Income Statement
In the last 12 months, Maravai Lifesciences Holdings had revenue of 185.74M and earned -130.77M in profits. Earnings per share was -0.91.
- Revenue
- 185.74M
- Gross Profit
- 33.39M
- Operating Income
- -6.74M
- Pretax Income
- -234.97M
- Net Income
- -130.77M
- EBITDA
- -147.51M
- Earnings Per Share (EPS)
- -0.91
Cash Flow
In the last 12 months, operating cash flow was -5.10M and capital expenditures -7.44M, giving a free cash flow of -12.54M billion.
- Operating Cash Flow
- -5.10M
- Free Cash Flow
- -12.54M
- Free Cash Flow per Share
- -0.08
Dividends & Yields
Maravai Lifesciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.60%
- Earnings Yield
- -5.97%
Stock Price Statistics
- Beta
- 1.43
- 52-Week Price Change
- 103.87%
- 50-Day Moving Average
- 7.40
- 200-Day Moving Average
- 5.48
- Relative Strength Index (RSI)
- 48.12
- Average Volume (3m)
- 2.96M
Important Dates
Maravai Lifesciences Holdings upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Maravai Lifesciences Holdings as a current ratio of 6.60, with Debt / Equity ratio of 16.75%
- Current Ratio
- 6.60
- Quick Ratio
- 5.69
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 1.23
- Interest Coverage Ratio
- -0.25
Taxes
In the past 12 months, Maravai Lifesciences Holdings has paid -4.21M in taxes.
- Income Tax
- -4.21M
- Effective Tax Rate
- 0.02
Enterprise Valuation
Maravai Lifesciences Holdings EV to EBITDA ratio is -54.90, with an EV/FCF ratio of -179.30.
- EV to Sales
- 10.56
- EV to EBITDA
- -54.90
- EV to Free Cash Flow
- -179.30
- EV to Operating Cash Flow
- -441.21
Balance Sheet
Maravai Lifesciences Holdings has $73.02M in cash and marketable securities with $225.90M in debt, giving a net cash position of -$152.87M billion.
- Cash & Marketable Securities
- $73.02M
- Total Debt
- $225.90M
- Net Cash
- -$152.87M
- Net Cash Per Share
- -$1.02
- Tangible Book Value Per Share
- $0.54
Margins
Gross margin is 38.87%, with operating margin of -18.77%, and net profit margin of -30.83%.
- Gross Margin
- 38.87%
- Operating Margin
- -18.77%
- Pretax Margin
- -54.19%
- Net Profit Margin
- -30.83%
- EBITDA Margin
- -19.23%
- EBIT Margin
- -44.26%
Analyst Forecast
The average price target for Maravai Lifesciences Holdings is $9.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $9.50
- Price Target Upside
- 28.73% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 10.77%
- EPS Growth Forecast
- 46.91%
Scores
- Smart Score
- 10
- AI Score
- 52

